iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion Systemnews2026-01-14T13:44:21+00:00January 14th, 2026|Medical Device News Magazine|
FDA delays decision on expanding label for Travere’s kidney disorder drugnews2026-01-13T21:19:40+00:00January 13th, 2026|Endpoints News|
FDA requests flu vaccine label updates to include febrile seizure risknews2026-01-13T19:54:18+00:00January 13th, 2026|Endpoints News|
FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labelsnews2026-01-13T19:00:55+00:00January 13th, 2026|Endpoints News|
Sentynl gets the first US approval for rare copper absorption diseasenews2026-01-13T10:49:44+00:00January 13th, 2026|Endpoints News|
Congress’ biotech panel pitches FDA policy upgrades to help performancenews2026-01-13T05:01:10+00:00January 13th, 2026|Endpoints News|
At FDA’s request, Pfizer helps ease shortage of potential autism drugnews2026-01-12T19:49:26+00:00January 12th, 2026|Endpoints News|
FDA shares eased manufacturing rules for cell and gene therapiesnews2026-01-12T18:04:55+00:00January 12th, 2026|Endpoints News|
FDA lifts partial hold on Merck, Daiichi’s Phase 3 lung cancer studynews2026-01-12T17:47:28+00:00January 12th, 2026|Endpoints News|
FDA again rejects Atara, Pierre Fabre’s cell therapy for Epstein-Barr virusnews2026-01-12T13:59:22+00:00January 12th, 2026|Endpoints News|
